- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03304184
The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life
June 28, 2021 updated by: Elizabeth Van Tubergen, University of Michigan
The study will compare two different dental materials on dental lesions near the gum line that cause chronic pain on oral health related quality of life.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The study will compare two different dental materials on dental lesions near the gum line.
One of the materials is tooth colored and the other material is white but both materials use different mechanisms to attach to the teeth and may have different outcomes.
The study will determine if one material is more effective in relieving chronic pain.
In addition, we will evaluate changes in oral health related quality of life after the placement of the two different dental materials.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- Dental School
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 64 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males and females age 18-64
- Chief complaint associated with pain from cold or hot
- Chronic sensitivity associated with supragingival lesions
- Pain not associated with decay
- Fluent in English and able to read English at a 6th grade level
- Pulpal response <40 via pulp tester
- Active salivary flow from palpation of parotid and submandibular glands
- Patients self reporting pain over 6/10 in the past week and/or the past 2 months
Exclusion Criteria:
- Pregnant women
- Patients taking benzodiazepines, narcotics and multiple antidepressants for pain management not associated with the oral cavity
- Unexplained dry mouth
- Patients taking two or more medications associated with dry mouth
- Pulpal response >40 via pulp tester
- Patients requiring treatment for more than 5 decayed sites, periodontal disease and root canal therapy
- Complicated medical history (>4 concurrent treatment for systemic diseases)
- Lesion >1mm below the gum line
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: Photac-fil
Participants will have a restoration placed with photac-fil in the lesion near the gum line.
|
Application of a tooth colored filling in a non-cavitated dental lesion.
Other Names:
|
|
EXPERIMENTAL: Biodentine
Participants will have a restoration placed with Biodentine in the lesion near the gum line.
|
Application of a white colored filling in a non-cavitated dental lesion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Global Base Changes of Pain
Time Frame: baseline, week1, week 2, 3 month follow up
|
A one survey description detailing the changes in pain over time based on the following scale:
|
baseline, week1, week 2, 3 month follow up
|
|
Oral Health Related Quality of Life Using a Survey With 49 Questions
Time Frame: Baseline, week1, week 2, 3 month follow up
|
A survey of 49 questions to assess oral health related quality of life.
The scale measured 49 questions with a yes (1) or no (0) answers with a possible range of 0-49.
The more answers of yes will indicate a higher score on the survey, which describes poorer oral health related quality of life.
A lower number reflects better oral health related quality of life.
A maximum score of 49 is the worst outcome.
|
Baseline, week1, week 2, 3 month follow up
|
|
Brief Pain Inventory
Time Frame: Baseline, week1, week 2, 3 month follow up
|
6 questions were used to measure pain on a sliding scale from 1-100 at each time point.
The scale ranged from 1 being no pain and 100 being extreme pain.
The higher the number reflects worse the pain compared to a lower number.
The maximum range from the participants was 600 (maximum) and the lowest range of 0 for all questions.
The data reflects the averaged sum for each time point for all patients in each arm.
|
Baseline, week1, week 2, 3 month follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 28, 2017
Primary Completion (ACTUAL)
October 9, 2019
Study Completion (ACTUAL)
October 9, 2019
Study Registration Dates
First Submitted
October 3, 2017
First Submitted That Met QC Criteria
October 5, 2017
First Posted (ACTUAL)
October 6, 2017
Study Record Updates
Last Update Posted (ACTUAL)
July 19, 2021
Last Update Submitted That Met QC Criteria
June 28, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- HUM00111890
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
Clinical Trials on Photac-fil
-
Al-Azhar UniversityCompleted
-
Centre Hospitalier Intercommunal de Toulon La Seyne...French Cardiology SocietyCompletedHeart Failure AcuteFrance
-
Cairo UniversityNot yet recruiting
-
Recep Tayyip Erdogan University Training and Research...WithdrawnNoncarious Cervical LesionsTurkey
-
Cairo UniversityNot yet recruiting
-
Suez Canal UniversityCompleted
-
Nuh Naci Yazgan UniversityTC Erciyes UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterStanford University; Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruiting